Langerhans cell histiocytosis vs Erdheim-Chester disease
How to tell Langerhans cell histiocytosis and Erdheim-Chester disease apart when a board question makes them look alike.
LCH is CD1a/langerin/Birbeck with lytic lesions; Erdheim-Chester is CD68-positive/CD1a-negative foamy histiocytes with symmetric osteosclerosis.
Side by side
Langerhans cell histiocytosis features clonal dendritic cells with grooved nuclei, Birbeck granules, CD1a, S100, and langerin/CD207 positivity; children can have punched-out lytic skull lesions, rash, diabetes insipidus, or lung disease.
Erdheim-Chester disease is a non-Langerhans histiocytosis with foamy CD68-positive/CD1a-negative histiocytes, symmetric long-bone osteosclerosis, hairy kidneys or coated aorta imaging clues, retroperitoneal/cardiovascular involvement, and frequent MAPK pathway mutations.
Clonal Langerhans-type dendritic cells infiltrate tissue and provoke inflammatory lesions.
Clonal macrophage-lineage histiocytes infiltrate bone and organs, often through MAPK pathway activation such as BRAF V600E.
CD1a, S100, langerin/CD207, Birbeck granules, punched-out lytic lesions, and eosinophil-rich lesions support Langerhans cell histiocytosis.
CD68-positive, CD1a-negative foamy histiocytes with symmetric osteosclerotic long-bone lesions, hairy kidneys, or coated aorta support Erdheim-Chester disease.
The trap
Both are histiocytic disorders and may involve BRAF, so cell markers and bone pattern are the fastest separators.
The repair move
For histiocytosis, match the marker profile to the bone pattern before naming the disease.
Try a free question
CoreA child has lytic skull lesions, rash, diabetes insipidus, and biopsy showing grooved cells with Birbeck granules that are CD1a, S100, and langerin positive. Which diagnosis is most likely?
Show answer and explanation
Answer: A. Langerhans cell histiocytosis. CD1a/langerin-positive grooved cells with Birbeck granules and lytic lesions point to LCH.
Why the other choices are tempting
- B. Erdheim-Chester disease is CD68-positive/CD1a-negative with symmetric osteosclerosis.
- C. Multiple myeloma causes plasma-cell lytic lesions with monoclonal protein in older adults.
- D. Paget disease causes focal high-turnover remodeling with mosaic bone.
- E. Osteopetrosis causes dense brittle bone from osteoclast dysfunction.
Flashcards
Tap a card to flip it.
What ultrastructural clue points to LCH?
Birbeck granules point to Langerhans cell histiocytosis.
What markers point to LCH?
CD1a, S100, and langerin/CD207 positivity point to LCH.
Quick answers
What is the fastest way to tell Langerhans cell histiocytosis from Erdheim-Chester disease?
LCH is CD1a/langerin/Birbeck with lytic lesions; Erdheim-Chester is CD68-positive/CD1a-negative foamy histiocytes with symmetric osteosclerosis.
What is the key clue for Langerhans cell histiocytosis?
Langerhans cell histiocytosis features clonal dendritic cells with grooved nuclei, Birbeck granules, CD1a, S100, and langerin/CD207 positivity; children can have punched-out lytic skull lesions, rash, diabetes insipidus, or lung disease.
What is the key clue for Erdheim-Chester disease?
Erdheim-Chester disease is a non-Langerhans histiocytosis with foamy CD68-positive/CD1a-negative histiocytes, symmetric long-bone osteosclerosis, hairy kidneys or coated aorta imaging clues, retroperitoneal/cardiovascular involvement, and frequent MAPK pathway mutations.
What is the common trap with Langerhans cell histiocytosis vs Erdheim-Chester disease?
Both are histiocytic disorders and may involve BRAF, so cell markers and bone pattern are the fastest separators.